-
Study aim
-
According to the results of this study, it is possible to choose a drug with appropriate efficiency and minimal harm as an additive to bupivacaine in terms of duration of sensitivity of sensory and motor block, time of block onset and side effects in epidural anesthesia for lower limb surgery.
-
Design
-
A double-blind, randomized, phase 3 clinical trial on 50 patients, the random permutation block method is used for randomly assigning patients to study groups, and finally, the data collected for data analysis from + tests ( If necessary, Mann-Whitney) and chi-square test will be used, and if necessary, linear regression and logistic regression will be used for multivariate data analysis, and all analyzes will be done using spss version 20 software.
-
Settings and conduct
-
Upon entering the operating room, the research is explained to all the participants and they are assured about the confidentiality of the information, then after obtaining permission from the patients, a written consent form is obtained to enter the study using the information in the file. Medicine, medical history of patients is collected.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria include patients aged 18-60 years with anesthesia risk ASA I, II candidates for lower limb orthopedic surgery, exclusion criteria include patients with local infection at the site of epidural block, patients who are allergic to the study drugs, patients who during The operation requires receiving analgesia, patients whose epidural block failed and were subjected to general anesthesia.
-
Intervention groups
-
BD group underwent epidural block with bupivacaine and dexmedetomidine and BM group underwent epidural block with bupivacaine and magnesium sulfate.
-
Main outcome variables
-
Visual Analogue Scale (VAS) Score